IncobotulinumtoxinA for Treatment of Focal Cancer Pain After Surgery and/or Radiation
Phase of Trial: Phase II
Latest Information Update: 12 Dec 2017
Price : $35 *
At a glance
- Drugs Botulinum-Toxin-A (Primary) ; Botulinum-Toxin-A (Primary)
- Indications Cancer pain
- Focus Therapeutic Use
- 30 Dec 2015 Status changed from recruiting to discontinued as per ClinicalTrials.gov record.
- 13 Apr 2015 According to the ClinicalTrials.gov record, planned end date changed from 1 Dec 2015 to 1 Jul 2016.
- 13 Apr 2015 According to the ClinicalTrials.gov record, planned primary completion date changed from 1 Dec 2014 to 1 Jul 2016.